In vivo pharmacokinetics of radioiodinated urokinase plasminogen activator (uPA) inhibitors for imaging metastatic cancer

Simple item page
dc.contributor.authorBerghofer, PJen_AU
dc.contributor.authorGreguric, Ien_AU
dc.contributor.authorShepherd, Ren_AU
dc.contributor.authorKatsifis, Aen_AU
dc.contributor.authorRanson, Men_AU
dc.contributor.authorVine, KLen_AU
dc.date.accessioned2014-07-15T02:03:20Zen_AU
dc.date.available2014-07-15T02:03:20Zen_AU
dc.date.issued2011-07-01en_AU
dc.date.statistics2014-07-15en_AU
dc.description.abstractTo determine and compare the in vivo tissue distribution, tumour uptake and clearance patterns of PAI2 and PAI2 Δ CD-loop radiolabelled indirectly with Iodine 123 for evaluation as imaging and therapeutic tools in prostate cancer.© 2011, Wiley-Blackwell.en_AU
dc.identifier.citationBerghhofer, P., Greguric, I., Shepherd, R., Katsifis, A., Ranson, M., & Vine, K. (2011). In vivo pharmacokinetics of radioiodinated urokinase plasminogen activator (upa) inhibitors for imaging metastatic cancer. Internal Medicine Journal, 41, 9-10. doi:10.1111/j.1445-5994.2011.02530.xen_AU
dc.identifier.govdoc5277en_AU
dc.identifier.issn1444-0903en_AU
dc.identifier.journaltitleInternal Medicine Journalen_AU
dc.identifier.pagination9-10en_AU
dc.identifier.urihttp://dx.doi.org/10.1111/j.1445-5994.2011.02530.xen_AU
dc.identifier.urihttp://apo.ansto.gov.au/dspace/handle/10238/5756en_AU
dc.identifier.volume41en_AU
dc.language.isoenen_AU
dc.publisherWiley-Blackwellen_AU
dc.subjectIn vivoen_AU
dc.subjectDistributionen_AU
dc.subjectIodineen_AU
dc.subjectProstateen_AU
dc.subjectNeoplasmsen_AU
dc.subjectOrgansen_AU
dc.titleIn vivo pharmacokinetics of radioiodinated urokinase plasminogen activator (uPA) inhibitors for imaging metastatic canceren_AU
dc.typeJournal Articleen_AU
Files
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Journal Articles